Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients

ConclusionsPharmacokinetically-targeted dosing appears to increase everolimus tolerability. This finding may be applicable to other patient populations.
Source: Cancer Chemotherapy and Pharmacology - Category: Cancer & Oncology Source Type: research